TY  - JOUR
PY  - 2018//
TI  - Association of prescription drug monitoring program use with opioid prescribing and health outcomes: a comparison of program users and non-users
JO  - Journal of Pain
A1  - Deyo, Richard A.
A1  - Hallvik, Sara E.
A1  - Hildebran, Christi
A1  - Marino, Miguel
A1  - Springer, Rachel
A1  - Irvine, Jessica M.
A1  - O'Kane, Nicole
A1  - Van Otterloo, Joshua
A1  - Wright, Dagan A.
A1  - Leichtling, Gillian
A1  - Millet, Lisa M.
A1  - Carson, Jody
A1  - Wakeland, Wayne
A1  - McCarty, Dennis
SP  - 166
EP  - 177
VL  - 19
IS  - 2
N2  - Prescription drug monitoring programs (PDMPs) are a response to the prescription opioid epidemic, but their impacts on prescribing and health outcomes remain unclear, with conflicting reports. We sought to determine if prescriber use of Oregon's prescription drug monitoring program (PDMP) led to fewer high-risk opioid prescriptions or overdose events. We conducted a retrospective cohort study from October, 2011 through October, 2014, using statewide PDMP data, hospitalization registry, and vital records. Early PDMP registrants (n=927) were matched with clinicians who never registered during the study period, using baseline prescribing metrics in a propensity score. Generalized estimating equations were used to examine prescribing trends following PDMP registration, using 2-month intervals. We found a statewide decline in measures of per capita opioid prescribing. However, compared with non-registrants, PDMP registrants did not subsequently have significantly fewer patients receiving high-dose prescriptions; overlapping opioid and benzodiazepine prescriptions, inappropriate prescriptions, prescriptions from multiple prescribers, or overdose events. At baseline, frequent PDMP users wrote fewer high-risk opioid prescriptions than infrequent users; this persisted during follow-up with few significant group differences in trend. Thus, although opioid prescribing declined statewide after implementing the PDMP, registrants did not demonstrate greater declines than non-registrants. PERSPECTIVE: Factors other than PDMP use may have had greater influence on prescribing trends. Refinements in the PDMP program and related policies may be necessary to increase PDMP impact.<br><br>Copyright © 2017. Published by Elsevier Inc.<p />  <p>Language: en</p>
LA  - en
SN  - 1526-5900
UR  - http://dx.doi.org/10.1016/j.jpain.2017.10.001
ID  - ref1
ER  -